MedTrace Logo

Clinical Study to Assess Safety and Efficacy of a New Armsleeve in the Management of Arm Lymphoedema

NCT02253186 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2015-12-07

No results posted yet for this study

Summary

The objective of the study is to assess the effect of a new Armsleeve, worn during the night during maintenance phase of upper limb lymphoedema treatment in combination with Day-time usual lymphology hosiery.

Conditions

  • Lymphedema

Interventions

DEVICE

Auto-Adjustable MOBIDERM Armsleeve

Sponsors & Collaborators

  • Thuasne

    lead INDUSTRY

Principal Investigators

  • Isabelle Quere, Prof · University Hospital, Montpellier

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02253186 on ClinicalTrials.gov